Rising insulin prices are hitting the national news, and Lancaster County diabetics know why.
Thanks to good insurance, she paid only
"It's quite unfortunate and very scary for us to think that some of us will have to choose to either not take or skip doses of insulin, because we won't be able to afford it," said the 31-year-old Strasburg resident.
As a result, he said, sometimes he skips doses - a situation his doctor is "not happy about at all."
A recent study published in the
Former presidential candidate and
"The original insulin patent expired 75 years ago," he wrote. "Instead of falling prices, as one might expect after decades of competition, three drugmakers who make different versions of insulin have continuously raised prices for this life-saving medication."
Pharmaceutical companies say their revenues from insulin have stayed the same over the years and that the market is highly competitive.
They point fingers at pharmacy benefit managers - middlemen who negotiate drug prices on behalf of insurance companies or employers. The higher list prices, drugmakers say, let them offer higher discounts to such middlemen, who compete on the basis of discounts they can earn for their clients.
He called questions about the consumer cost of drugs "a constant," and said that "unfortunately, it often impacts the treatment negatively."
"I only prescribe the cheap generics," Loeven said. "With the medicines I use frequently I have a pretty good handle on the costs and how to get those costs lower, whether it's through pointing people to websites or price matching."
Local insurers say they work to get their members affordable coverage.
Further, Capital BlueCross spokeswoman